手术植入的临时心室辅助 - "Impella 5.5"
Akshay Chauhan1, Mikiko Senzai1, Sriram Vijayapuri1
1Department of Cardiovascular Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19004 USA.
Indian journal of thoracic and cardiovascular surgery
|June 19, 2025
概括
伊佩拉5.5左心室辅助装置为严重心力衰竭提供短期的心脏支持. 证据证实它在改善心脏输出和器官输液方面的有效性,尽管存在潜在风险.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 机械循环支持 机械循环支持
背景情况:
- 严重的心力衰竭和心脏性休克需要先进的心脏支持.
- 伊佩拉5.5是一个以导管为基础的左心室辅助装置,旨在提供短期的机械支持.
- 它的设计在轻松插入和最小的后负载增加方面具有优势.
研究的目的:
- 为了提供对Impella 5.5设备的全面分析.
- 审查其设计,临床应用,好处和挑战.
- 根据最近的证据,重新评估其在治疗严重心力衰竭和心脏性休克中的作用.
主要方法:
- 临床试验和现实世界的证据的审查.
- 分析器械设计和手术植入策略.
- 评估患者的结果和潜在的并发症.
主要成果:
- 伊佩拉5.5有效地提高了心脏输出和器官 perfusion.
- 短期支持与心脏性休克改善的结果有关.
- 确定的风险包括出血,血管并发症和血液溶解.
结论:
- 适当的患者选择,手术规划和插入后管理对于Impella 5.5的使用至关重要.
- 需要对长期结果,成本效益和技术进步进行进一步的研究.
- 伊佩拉5.5在治疗急性心脏病方面发挥着重要作用.
相关概念视频
01:29Cardiomyopathy V: Interprofessional Care
41
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
41
01:22Heart Failure VI: Adjunct Therapies
39
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
39